MESALAMINE | A208362 | AMRING PHARMACEUTICALS INC
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Aptalis Pharma US, Inc. et al v. Delcor Asset Corporation et al 3 patentsANDA 208362mesalamine | D. Del. | 2015-12-27 | Terminated 2016-04-19 | — |
APTALIS PHARMA US, INC. et al v. DELCOR ASSET CORPORATION et al 3 patentsANDA 208362mesalamine | D.N.J. | 2015-12-23 | Terminated 2016-04-20 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$1.33
per ea
Lowest NADAC/Unit
$1.33
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 69918056030MESALAMINE 1,000 MG SUPP | $1.33 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.